Concepedia

Ulrike Fasol

UF

7

Publications

564

Citations

7

H-Index

2005

Active since

Affiliations

University Medical Center Freiburg(Current)

Bayer (Germany)

University of Freiburg

Ulrike Fasol is an author at University Medical Center Freiburg specializing in cancer research, cancer therapeutics, and pharmacotherapy.

Top concepts

Publications per year

2005–2012

7

Publications

7

A Phase I Dose–Escalation Study of Regorafenib (BAY 73–4506), an Inhibitor of Oncogenic, Angiogenic, and Stromal Kinases, in Patients with Advanced Solid Tumors

K. Mross, Annette Frost, Simone Steinbild et al. · Clinical Cancer Research · 2012 · 329 citations

Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis

Ulrike Fasol, Annette Frost, Martin Büchert et al. · Annals of Oncology · 2011 · 104 citations · Full text

, , +13

DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study

K. Mross, Ulrike Fasol, Annette Frost et al. · Journal of Angiogenesis Research · 2009 · 54 citations · Full text

Fast oxygen‐enhanced multislice imaging of the lung using parallel acquisition techniques

Olaf Dietrich, Christoph Losert, Ulrike Attenberger et al. · Magnetic Resonance in Medicine · 2005 · 38 citations

Onset and Maintenance of Angiogenesis in Biomaterials: <i>In Vivo</i> Assessment by Dynamic Contrast-Enhanced MRI

Sebastian Sauerbier, Moritz Palmowski, Michael Vogeler et al. · Tissue Engineering Part C Methods · 2009 · 14 citations

Rows per page

1–5 of 7